Services
US$ 21.57
glp 1 and heart failure GLP-1 Receptor Agonists in Vascular and metabolic effects of
Description
Tirzepatide was approved in 2022 as Mounjaro for diabetes, and in 2024 as Zepbound for obesity, with exclusivity running until May 2027
What is Retatrutide
For humans, the model-predicted median clearance (CL) and volume of distribution (Vss) of semaglutide were 0.0397 L/h and 6.23 L, respectively
Drugmaker Eli Lilly announced the FDA approved its oral GLP-1 pill, called Foundayo.
With the rise in use of GLP-1 drugs, health insurers must balance these drugs proven effectiveness with the cost of treatment
But for complex drugs like this, quality control is still improving
